308 related articles for article (PubMed ID: 27662269)
1. Breaking Hepatitis B Virus Tolerance and Inducing Protective Immunity Based on Mimicking T Cell-Independent Antigen.
Li X; Ni R
Viral Immunol; 2016 Nov; 29(9):502-509. PubMed ID: 27662269
[TBL] [Abstract][Full Text] [Related]
2. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
3. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
4. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
5. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
[TBL] [Abstract][Full Text] [Related]
6. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccines: protective efficacy and therapeutic potential.
Michel ML; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
[TBL] [Abstract][Full Text] [Related]
10. Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination.
Zhu D; Liu L; Yang D; Fu S; Bian Y; Sun Z; He J; Su L; Zhang L; Peng H; Fu YX
J Immunol; 2016 Apr; 196(7):3079-87. PubMed ID: 26936879
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
12. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
13. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.
Roh S; Kim K
Microbiol Immunol; 2003; 47(6):453-60. PubMed ID: 12906106
[TBL] [Abstract][Full Text] [Related]
14. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.
Rybczynska J; Campbell K; Kamili S; Locarnini S; Krawczynski K; Walker CM
J Infect Dis; 2016 Jan; 213(1):49-56. PubMed ID: 26324781
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B: 50 years after the discovery of Australia antigen.
Lok AS
J Viral Hepat; 2016 Jan; 23(1):5-14. PubMed ID: 26280668
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
Lan P; Zhang C; Han Q; Zhang J; Tian Z
Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
[TBL] [Abstract][Full Text] [Related]
20. Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV.
Morrey JD; Motter NE; Chang S; Fairman J
Antiviral Res; 2011 Jun; 90(3):227-30. PubMed ID: 21545812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
